Perioperative Myocardial Infarction Diagnosis in Patients with Chronic Kidney Disease and Heart Failure

Diagnostic Criteria

The American College of Cardiology recommends that a perioperative MI is diagnosed when a rise in troponin of ≥20% from the most recent pre-procedure level is combined with new ECG changes, such as new pathologic Q-waves in ≥2 contiguous leads, new persistent LBBB, or ischemic ST-segment changes, in patients with CKD and HF undergoing noncardiac surgery 1
For patients with elevated baseline troponin, the diagnostic approach differs fundamentally from those with normal baseline values, requiring an absolute increment equal to ≥10× the upper limit of normal (ULN) from the most recent pre-procedure level for CK-MB, or ≥70× ULN for standard troponin, plus additional criteria such as new pathologic Q-waves or new persistent LBBB 1

The American College of Cardiology suggests using standard troponin assays over high-sensitivity troponins for periprocedural MI assessment, as high-sensitivity assays may lead to overdiagnosis 1
A 20% relative increase from baseline is the key threshold when baseline troponin is already elevated and stable or falling, applicable to patients with CKD and HF 2, 3

The diagnosis of perioperative MI requires both biomarker and clinical criteria, including new ischemic ECG changes, angiographic evidence of flow-limiting complications, new loss of viable myocardium on imaging, or clinical symptoms consistent with myocardial ischemia 1, 3

Even without meeting full MI criteria, any troponin elevation in the perioperative period carries significant prognostic weight, with post-operative troponin levels correlating with 30-day mortality 4, 6
The magnitude of change from baseline correlates with prognosis, with larger changes predicting worse outcomes 4, 3

Serial testing is mandatory in CKD/HF patients because a single elevated value is non-diagnostic, and the diagnosis of AMI requires demonstrating a dynamic change rather than a static elevation 2, 5
Absolute changes in troponin during serial sampling do not differ between MI patients with and without CKD, and a 3-hour interval between measurements is recommended for hospitalized patients 5, 3